These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21383300)

  • 1. Molecular remission in follicular lymphoma: is the era of residual disease monitoring over?
    Procházka V; Papajík T
    J Clin Oncol; 2011 Apr; 29(11):e318; author reply e319. PubMed ID: 21383300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of molecular remission in follicular lymphoma.
    Dührsen U; Hüttmann A; Dürig J
    J Clin Oncol; 2010 Oct; 28(30):e613; author reply e614. PubMed ID: 20713852
    [No Abstract]   [Full Text] [Related]  

  • 4. BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
    van Oers MH; Tönnissen E; Van Glabbeke M; Giurgea L; Jansen JH; Klasa R; Marcus RE; Wolf M; Kimby E; Vranovsky A; Holte H; Hagenbeek A; van der Reijden BA
    J Clin Oncol; 2010 May; 28(13):2246-52. PubMed ID: 20368567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.
    Inogès S; Rodrìguez-Calvillo M; Zabalegui N; Lòpez-Dìaz de Cerio A; Villanueva H; Soria E; Suárez L; Rodríguez-Caballero A; Pastor F; García-Muñóz R; Panizo C; Pèrez-Calvo J; Melero I; Rocha E; Orfao A; Bendandi M; ;
    J Natl Cancer Inst; 2006 Sep; 98(18):1292-301. PubMed ID: 16985248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rituximab (antiCD20 monoclonal antibody) and molecular-biological negativity in the treatment of patients with follicular lymphoma--a way to a cure?--Editorial].
    Trnený M
    Vnitr Lek; 2007 Oct; 53(10):1029-30. PubMed ID: 18072423
    [No Abstract]   [Full Text] [Related]  

  • 9. Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
    Noriega MF; De Brasi C; Narbaitz M; Rodríguez A; Slavutsky I
    Pathology; 2010; 42(6):598-601. PubMed ID: 20854087
    [No Abstract]   [Full Text] [Related]  

  • 10. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
    Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
    Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
    Yáñez R; Barrios Y; Ruiz E; Cabrera R; Díaz-Espada F
    J Immunother; 2008 Apr; 31(3):310-2. PubMed ID: 18317357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
    Rohatiner A; Radford J; Deakin D; Earl H; Love SB; Price O; Wilson A; Lister TA
    Br J Cancer; 2001 Jul; 85(1):29-35. PubMed ID: 11437398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.
    Pennell N; Woods A; Reis M; Buckstein R; Spaner D; Imrie K; Hewitt K; Boudreau A; Seth A; Berinstein NL
    J Mol Diagn; 2006 Feb; 8(1):40-50. PubMed ID: 16436633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.